EIF2AK2 and melanoma: Overexpression of PKR or increased PKR activity is seen in pancreatic cancer [28], melanoma [97], colon cancer [97], breast cancer [98] and hepatocellular carcinoma [99], suggesting its role in tumorigenesis.